Skip to main content

Table 4 Therapeutic interventions in patients with sepsis and NeOAF

From: Prognostic impact of restored sinus rhythm in patients with sepsis and new-onset atrial fibrillation

  NeOAF patients (n = 240) P value
Overall (n = 240) NeOAF to SR (n = 165) NeOAF to AF (n = 75)
Pharmacological, n (%)
Amiodarone 80 (33.3) 52 (31.5) 28 (37.3) 0.38
Beta-blockers 88 (36.7) 67 (40.6) 21 (28.0) 0.06
Non-DHP CCBsa 66 (27.5) 47 (28.5) 19 (25.3) 0.61
Digoxin glycosides 27 (11.3) 15 (9.1) 12 (16.0) 0.12
Electrical cardioversion, n (%) 8 (3.3) 4 (2.4) 4 (5.3) 0.25
  1. NeOAF new-onset atrial fibrillation, AF atrial fibrillation, SR sinus rhythm. aOnly indicates non-dihydropyridine calcium channel blockers (non-DHP CCBs)